69794-203 : Crysvita 20 mg/ml Subcutaneous Injection
| NDC: | 69794-203 |
| Labeler: | Ultragenyx Pharmaceutical Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Crysvita |
| Dosage Form: | Subcutaneous Injection |
| Application #: | BLA761068 |
| Rev. Date: |
NDC Package Codes:
- 69794-203-01: 1 ML IN 1 VIAL, SINGLE‑USE (69794‑203‑01)
Active Ingredients:
- Burosumab
Dosage Strength:
- 20 mg/mL
Related Products:
Based on records with the same trade name.- 69794-102 Crysvita 10 mg/ml Subcutaneous Injection by Ultragenyx Pharmaceutical Inc.
- 69794-304 Crysvita 30 mg/ml Subcutaneous Injection by Ultragenyx Pharmaceutical Inc.
- 42747-102 Crysvita 10 mg/ml Subcutaneous Injection by Kyowa Kirin, Inc.
- 42747-203 Crysvita 30 mg/ml Subcutaneous Injection by Kyowa Kirin, Inc.
- 42747-304 Crysvita 20 mg/ml Subcutaneous Injection by Kyowa Kirin, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 69794-102Next: 69794-304 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.